JW (CAYMAN) THERAPEUTICS CO. LTD
(HKEX: 2126)
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
1.280 -
-0.070
(-5.19%)
Range
1.280 - 1.330
(3.91%)
Open
1.300
Previous Close
1.350
Bid Price
1.280
Bid Volume
('000)
8.5
Ask Price
1.290
Ask Volume
('000)
1.5
Volume
('000)
391.5
Value
508,470
Remark
-
Delayed prices. Updated at 20 Dec 2024 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
